Silver Nanoparticles in Poultry Production

Nanoparticles of silver (nano-Ag) is an emerging alternative feed supplement for poultry and likely for medical applications. As a result of nanosilver special characteristic of killing bacteria, antimicrobial materials containing nanosilver are becoming increasingly important because of their wide range of applications. Despite the widespread use of nanosilver products, relatively few studies have been undertaken to determine the biological effects of nano- silver exposure. The ultimate objective of this paper is to clarify the potential of nano-Ag as an alternative growth promoting supplement for chicken

Effect of Chinese Propolis Supplementation on Ross Broiler Chicks: Microbial Population in Fecal matter and Litter

Propolis has been considered a good candidate for health amelioration and disease prevention over a long period of time. Effect of feed supplementation with Chinese ether extract propolis was evaluated for the antibacterial action on (Ross 308) broiler chicks and their litter over 35 days. The addition of different levels of propolis (100, 250 and 750 mg/kg diet) on total aerobic and coliform bacteria as well as Lactobacillus spp. and bifidobacteria were determined. Supplementation of propolis significantly increased (p<0.05) the desired stimulating effect of Lactobacillus spp. and Bifidobacteria in fecal samples of all treatment groups compared to control group. However, propolis did not have an impact to reduce the total aerobic and coliform bacteria compared to control group in both fecal and litter samples. In conclusion, Chinese propolis improved the beneficial normal gut microflora and had a limited effect on the total aerobic and coliform bacteria in broiler chicks and litter quality

Effects of Propolis, Ascorbic Acid and Vitamin E on Thyroid and Corticosterone Hormones in Heat Stressed Broilers

The study was designed to evaluate the effect of oxidative stress during the summer on serum levels of Triiodothyronine (T3), thyroxine (T4) and corticosterone hormones in Ross 308 broiler chickens and to compare the efficacy of propolis, ascorbic acid and vitamin E (α-tocopherol acetate) as antioxidants in amelioration of heat stress and normalization of serum T3 and T4 and corticosterone levels in broilers. Birds were divided into five groups during the experimental period (15 to 42 days of age), the positive control group (G1) was kept under thermo-neutral condition (28.0±4.0°C ) and fed control diet, while the other four groups were exposed to heat stress (38.0±1.4°C), control group (G2) chicks were fed control diet without additives, propolis group (G3) chicks were supplemented with 250 mg Chinese ether extracted propolis /kg diet, group (G4) supplemented with 250 mg ascorbic acid/kg diet and group (G5) supplemented with 250 mg of α-tocopherol acetate/kg diet (vitamin E). At the end of day 42, five broilers were randomly chosen from each treatment and slaughtered, and then sera were collected to estimate T3 and T4 and corticosterone levels. The results indicated that dietary supplementation of broilers with 250 mg/kg diet propolis, vitamin E or vitamin C can attenuate heat stress induced oxidative damage. These positive effects were evidenced by reduced serum corticosterone levels and improvement in thyroid hormonal levels in comparison to non-supplemented birds reared under heat stress

The Effect of Chinese Propolis Supplementation on Ross Broiler Performance and Carcass Characteristics

The experiment was conducted to investigate the effects of Ether Extract of Propolis (EEP) on Ross (308) broiler performance and carcass characteristics. This experiment was carried out in a completely randomized design with 5 treatments (different levels of propolis including 0, 100, 250, 500 and 750 mg/kg diet) for 6 weeks. The mean weight gain, feed consumption and feed conversion ratio were recorded weekly. In addition At 42 days old the total body weight, total body weight gain, carcass and some internal organs relative weights were recorded. The results clarified that, the weight gain was significantly reduced in the 4th and 6th week (P<0.05), while the feed consumption, feed efficiency were non significantly (P>0.05) reduced for propolis fed birds in comparison to those fed control diet, Furthermore, inclusion of 100, 250, 500 and 750 mg/kg diet Propolis significantly reduced body weight at 42 days old and total body weight gain in comparison to control diet (P < 0.05). Under the condition of this experiment, prolonged use of propolis had adverse effect on performance of broilers. Also, all doses of propolis had non-significant negative effect on liver, heart, gizzard and carcass relative weight. In conclusion, EEP has no beneficial effect on performance and Carcass characteristics of Broilers

The Effect of Heat Stress on Blood Picture of Japanese Quail

This study aimed to evaluate the effect of heat stress on quail hematological parameters. A total number of 300 Japanese quail chicks (Coturnix Coturnix japonica) of 28 days old were exposed to different levels of raising temperatures (22, 29, 34, 36 and 40 ºC) for 15 days. At 42 days old, blood samples were collected from 14 birds (7 males + 7 females) that were randomly selected. The samples were used for determining red blood cells count, hemoglobin concentration, packed cell volume, total and differential white blood cells count, heterophils/ lymphocyte (H/L) ratio, mean corpuscular hemoglobin, mean corpuscular volume and mean corpuscular hemoglobin concentration. The obtained results indicated that, rearing quail birds under high environmental conditions during fattening period has a great adverse effect on these blood parameters

Metabolomic profile, anti-trypanosomal potential and molecular docking studies of <i>Thunbergia grandifolia</i>

Trypanosomiasis is a protozoan disease transmitted via Trypanosoma brucei. This study aimed to examine the metabolic profile and anti-trypanosomal effect of methanol extract of Thunbergia grandifolia leaves. The liquid chromatography-high resolution electrospray ionisation mass spectrometry (LC-HRESIMS) revealed the identification of fifteen compounds of iridoid, flavonoid, lignan, phenolic acid, and alkaloid classes. The extract displayed a promising inhibitory activity against T. brucei TC 221 with MIC value of 1.90 μg/mL within 72 h. A subsequent in silico analysis of the dereplicated compounds (i.e. inverse docking, molecular dynamic simulation, and absolute binding free energy) suggested both rhodesain and farnesyl diphosphate synthase as probable targets for two compounds among those dereplicated ones in the plant extract (i.e. diphyllin and avacennone B). The absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiling of diphyllin and avacennone were calculated accordingly, where both compounds showed acceptable drug-like properties. This study highlighted the antiparasitic potential of T. grandifolia leaves

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.

We report graft-versus-host disease (GVHD)-free relapse-free survival (GRFS) (a composite end point of survival without grade III-IV acute GVHD [aGVHD], systemic therapy-requiring chronic GVHD [cGVHD], or relapse) and cGVHD-free relapse-free survival (CRFS) among pediatric patients with acute leukemia (n = 1613) who underwent transplantation with 1 antigen-mismatched (7/8) bone marrow (BM; n = 172) or umbilical cord blood (UCB; n = 1441). Multivariate analysis was performed using Cox proportional hazards models. To account for multiple testing, P \u3c .01 for the donor/graft variable was considered statistically significant. Clinical characteristics were similar between UCB and 7/8 BM recipients, because most had acute lymphoblastic leukemia (62%), 64% received total body irradiation-based conditioning, and 60% received anti-thymocyte globulin or alemtuzumab. Methotrexate-based GVHD prophylaxis was more common with 7/8 BM (79%) than with UCB (15%), in which mycophenolate mofetil was commonly used. The univariate estimates of GRFS and CRFS were 22% (95% confidence interval [CI], 16-29) and 27% (95% CI, 20-34), respectively, with 7/8 BM and 33% (95% CI, 31-36) and 38% (95% CI, 35-40), respectively, with UCB (P \u3c .001). In multivariate analysis, 7/8 BM vs UCB had similar GRFS (hazard ratio [HR], 1.12; 95% CI, 0.87-1.45; P = .39), CRFS (HR, 1.06; 95% CI, 0.82-1.38; P = .66), overall survival (HR, 1.07; 95% CI, 0.80-1.44; P = .66), and relapse (HR, 1.44; 95% CI, 1.03-2.02; P = .03). However, the 7/8 BM group had a significantly higher risk for grade III-IV aGVHD (HR, 1.70; 95% CI, 1.16-2.48; P = .006) compared with the UCB group. UCB and 7/8 BM groups had similar outcomes, as measured by GRFS and CRFS. However, given the higher risk for grade III-IV aGVHD, UCB might be preferred for patients lacking matched donors. © 2019 American Society of Hematology. All rights reserved

Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants

Optimal donor selection is critical for successful allogeneic hematopoietic cell transplantation (HCT). Donor sex and parity are well-established risk factors for graft-versus-host disease (GVHD), with male donors typically associated with lower rates of GVHD. Well-matched unrelated donors (URDs) have also been associated with increased risks of GVHD as compared with matched sibling donors. These observations raise the question of whether male URDs would lead to more (or less) favorable transplant outcomes as compared with parous female sibling donors. We used the Center for International Blood and Marrow Transplant Research registry to complete a retrospective cohort study in adults with acute myeloid leukemia, acute lymphoblastic leukemia, or myelodysplastic syndrome, who underwent T-cell replete HCT from these 2 donor types (parous female sibling or male URD) between 2000 and 2012. Primary outcomes included grade 2 to 4 acute GVHD (aGVHD), chronic GVHD (cGVHD), and overall survival. Secondary outcomes included disease-free survival, transplant-related mortality, and relapse. In 2813 recipients, patients receiving male URD transplants (n = 1921) had 1.6 times higher risk of grade 2 to 4 aGVHD (P \u3c .0001). For cGVHD, recipient sex was a significant factor, so donor/recipient pairs were evaluated. Female recipients of male URD grafts had a higher risk of cGVHD than those receiving parous female sibling grafts (relative risk [RR] = 1.43, P \u3c .0001), whereas male recipients had similar rates of cGVHD regardless of donor type (RR = 1.09, P = .23). Donor type did not significantly affect any other end point. We conclude that when available, parous female siblings are preferred over male URDs

Improved survival after acute graft-

A cute graft- versus -host disease remains a major threat to a successful outcome after allogeneic hematopoietic cell transplantation. While improvements in treatment and supportive care have occurred, it is unknown whether these advances have resulted in improved outcome specifically among those diagnosed with acute graft- versus -host disease. We examined outcome following diagnosis of grade II-IV acute graft- versus -host disease according to time period, and explored effects according to original graft- versus -host disease prophylaxis regimen and maximum overall grade of acute graft- versus -host disease. Between 1999 and 2012, 2,905 patients with acute myeloid leukemia (56%), acute lymphoblastic leukemia (30%) or myelodysplastic syndromes (14%) received a sibling (24%) or unrelated donor (76%) blood (66%) or marrow (34%) transplant and developed grade II-IV acute graft- versus -host disease (n=497 for 1999-2001, n=962 for 2002-2005, n=1,446 for 2006-2010). The median (range) follow-up was 144 (4-174), 97 (4-147) and 60 (8-99) months for 1999-2001, 2002-2005, and 2006-2010, respectively. Among the cohort with grade II-IV acute graft- versus -host disease, there was a decrease in the proportion of grade III-IV disease over time with 56%, 47%, and 37% for 1999-2001, 2002-2005, and 2006-2012, respectively ( P <0.001). Considering the total study population, univariate analysis demonstrated significant improvements in overall survival and treatment-related mortality over time, and deaths from organ failure and infection declined. On multivariate analysis, significant improvements in overall survival ( P =0.003) and treatment-related mortality ( P =0.008) were only noted among those originally treated with tacrolimus-based graft- versus -host disease prophylaxis, and these effects were most apparent among those with overall grade II acute graft- versus -host disease. In conclusion, survival has improved over time for tacrolimus-treated transplant recipients with acute graft- versus -host disease